Previous close | 61.70 |
Open | 61.70 |
Bid | 61.02 x N/A |
Ask | 61.18 x N/A |
Day's range | 61.70 - 61.70 |
52-week range | 40.52 - 69.24 |
Volume | |
Avg. volume | 0 |
Market cap | N/A |
Beta (5Y monthly) | N/A |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | 31 Jul 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
When we're researching a company, it's sometimes hard to find the warning signs, but there are some financial metrics...
Scotts Miracle-Gro (SMG) lowers fiscal 2024 guidance for EBITDA and sales, citing weaker-than-expected May performance while reaffirming cost-saving and debt-reduction goals.
Key Takeaways; Cannabis Sector Canopy Growth to fully acquire Acreage Holdings in strategic move AFC Gamma exited its largest portfolio loan, securing 19.9% return. Green Thumb CEO confirmed proposal to Boston Beer. Scotts Miracle-Gro adjusted financial outlook for 2024 but maintained strategic goals. Key Takeaways; Psychedelic Sector Filament Health received FDA approval for a meth […]